XML 83 R103.htm IDEA: XBRL DOCUMENT v2.4.0.6
Supplemental Guarantor and Non-Guarantor Financial Information (Details 2) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
OPERATING ACTIVITIES:      
Net cash provided by operating activities $ 125,968 $ 5,141 $ 142,621
INVESTING ACTIVITIES:      
Purchase of fixed assets (11,779) (19,231) (16,184)
Proceeds from sale of businesses 9,220 146,315 9,796
Acquisition of businesses, net of cash acquired (22,335) (320) (834,919)
Net cash (used in) provided by investing activities (24,894) 126,764 (841,307)
FINANCING ACTIVITIES:      
Proceeds from issuance of common stock 3,980 7,901 8,618
Windfall tax benefits associated with equity-based compensation 88 192 948
Proceeds from issuance of debt 0 0 1,075,000
Borrowings under revolving credit facility 0 0 30,000
Repayment of borrowings under revolving credit facility 0 0 (30,000)
Repayment of long-term debt (52,943) (63,438) (260,437)
Repayment of Odyssey debt 0 0 (108,822)
Debt issuance costs (4,125) (15,460) (58,577)
Repurchase of common stock (4,974) 0 (4,985)
Repayment of capital lease obligations (135) (267) (645)
Other (825) (673) (72)
Net payments related to intercompany financing 0 0 0
Net cash (used in) provided by financing activities (58,934) (71,745) 651,028
Net change in cash and cash equivalents 42,140 60,160 (47,658)
Cash and cash equivalents at beginning of period 164,912 104,752 152,410
Cash and cash equivalents at end of period 207,052 164,912 104,752
Gentiva Health Services, Inc. [Member]
     
OPERATING ACTIVITIES:      
Net cash provided by operating activities (18,089) (46,730) (13,150)
INVESTING ACTIVITIES:      
Purchase of fixed assets 0 0 0
Proceeds from sale of businesses 0 0 0
Acquisition of businesses, net of cash acquired 0 0 0
Net cash (used in) provided by investing activities 0 0 0
FINANCING ACTIVITIES:      
Proceeds from issuance of common stock 3,980 7,901 8,618
Windfall tax benefits associated with equity-based compensation 88 192 948
Proceeds from issuance of debt     1,075,000
Borrowings under revolving credit facility     30,000
Repayment of borrowings under revolving credit facility     (30,000)
Repayment of long-term debt (52,943) (63,438) (260,437)
Repayment of Odyssey debt     0
Debt issuance costs (4,125) (15,460) (58,577)
Repurchase of common stock (4,974)   (4,985)
Repayment of capital lease obligations (135) (267) (645)
Other 4,673 0 (72)
Net payments related to intercompany financing 113,564 178,087 (796,095)
Net cash (used in) provided by financing activities 60,128 107,015 (36,245)
Net change in cash and cash equivalents 42,039 60,285 (49,395)
Cash and cash equivalents at beginning of period 124,101 63,816 113,211
Cash and cash equivalents at end of period 166,140 124,101 63,816
Guarantor Subsidiaries [Member]
     
OPERATING ACTIVITIES:      
Net cash provided by operating activities 138,316 51,221 156,227
INVESTING ACTIVITIES:      
Purchase of fixed assets (11,609) (19,053) (15,947)
Proceeds from sale of businesses 9,220 146,261 9,796
Acquisition of businesses, net of cash acquired (22,335) (320) (834,919)
Net cash (used in) provided by investing activities (24,724) 126,888 (841,070)
FINANCING ACTIVITIES:      
Proceeds from issuance of common stock 0 0 0
Windfall tax benefits associated with equity-based compensation 0 0 0
Proceeds from issuance of debt     0
Borrowings under revolving credit facility     0
Repayment of borrowings under revolving credit facility     0
Repayment of long-term debt 0 0 0
Repayment of Odyssey debt     (108,822)
Debt issuance costs 0 0 0
Repurchase of common stock 0   0
Repayment of capital lease obligations 0 0 0
Other (28) (22) 0
Net payments related to intercompany financing (113,564) (178,087) 793,665
Net cash (used in) provided by financing activities (113,592) (178,109) 684,843
Net change in cash and cash equivalents 0 0 0
Cash and cash equivalents at beginning of period 0 0 0
Cash and cash equivalents at end of period 0 0 0
Non-Guarantor Subsidiaries [Member]
     
OPERATING ACTIVITIES:      
Net cash provided by operating activities 5,741 650 (456)
INVESTING ACTIVITIES:      
Purchase of fixed assets (170) (178) (237)
Proceeds from sale of businesses 0 54 0
Acquisition of businesses, net of cash acquired 0 0 0
Net cash (used in) provided by investing activities (170) (124) (237)
FINANCING ACTIVITIES:      
Proceeds from issuance of common stock 0 0 0
Windfall tax benefits associated with equity-based compensation 0 0 0
Proceeds from issuance of debt     0
Borrowings under revolving credit facility     0
Repayment of borrowings under revolving credit facility     0
Repayment of long-term debt 0 0 0
Repayment of Odyssey debt     0
Debt issuance costs 0 0 0
Repurchase of common stock 0   0
Repayment of capital lease obligations 0 0 0
Other (5,470) (651) 0
Net payments related to intercompany financing 0 0 2,430
Net cash (used in) provided by financing activities (5,470) (651) 2,430
Net change in cash and cash equivalents 101 (125) 1,737
Cash and cash equivalents at beginning of period 40,811 40,936 39,199
Cash and cash equivalents at end of period 40,912 40,811 40,936
Eliminations [Member]
     
OPERATING ACTIVITIES:      
Net cash provided by operating activities 0 0 0
INVESTING ACTIVITIES:      
Purchase of fixed assets 0 0 0
Proceeds from sale of businesses 0 0 0
Acquisition of businesses, net of cash acquired 0 0 0
Net cash (used in) provided by investing activities 0 0 0
FINANCING ACTIVITIES:      
Proceeds from issuance of common stock 0 0 0
Windfall tax benefits associated with equity-based compensation 0 0 0
Proceeds from issuance of debt     0
Borrowings under revolving credit facility     0
Repayment of borrowings under revolving credit facility     0
Repayment of long-term debt 0 0 0
Repayment of Odyssey debt     0
Debt issuance costs 0 0 0
Repurchase of common stock 0   0
Repayment of capital lease obligations 0 0 0
Other 0 0 0
Net payments related to intercompany financing 0 0 0
Net cash (used in) provided by financing activities 0 0 0
Net change in cash and cash equivalents 0 0 0
Cash and cash equivalents at beginning of period 0 0 0
Cash and cash equivalents at end of period $ 0 $ 0 $ 0